Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan
针对既往接受过治疗且伴有腹膜播散的胃癌患者,采用溶剂型或白蛋白结合型紫杉醇联合雷莫芦单抗治疗,并进行预先设定的生物标志物分析(P-SELECT/WJOG10617G):一项在日本开展的随机II期临床试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2026.103768
Hirata, Kenro; Hamamoto, Yasuo; Shoji, Hirokazu; Hara, Hiroki; Kondoh, Chihiro; Yasui, Hisateru; Kajiwara, Takeshi; Baba, Eishi; Ando, Takayuki; Sugimoto, Naotoshi; Kawakami, Hisato; Katsuya, Hiroo; Nagase, Michitaka; Yamamoto, Yoshiyuki; Yoshimura, Kenichi; Ando, Masahiko; Imamura, Chiyo K; Yamazaki, Kentaro; Hironaka, Shuichi; Muro, Kei